| Neuroprotective agents target molecular mechanisms of disease in ALS Y Zhu, A Fotinos, LLJ Mao, N Atassi, EW Zhou, S Ahmad, Y Guan, ... Drug Discovery Today 20 (1), 65-75, 2015 | 39 | 2015 |
| Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy R S Pandya, L LJ Mao, E W Zhou, R Bowser, Z Zhu, Y Zhu, X Wang Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2012 | 35 | 2012 |
| N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model W Li, A Fotinos, Q Wu, Y Chen, Y Zhu, S Baranov, Y Tu, EW Zhou, ... Neurobiology of disease 80, 93-103, 2015 | 29 | 2015 |
| Comparison of research spending on new drug approvals by the national institutes of health vs the pharmaceutical industry, 2010-2019 EG Cleary, MJ Jackson, EW Zhou, FD Ledley JAMA Health Forum 4 (4), e230511-e230511, 2023 | 8 | 2023 |
| Melatonin in neuroskeletal biology A Patel, EW Zhou, M O'Brien, X Wang, S Zhou Current Opinion in Pharmacology 61, 42-48, 2021 | 6 | 2021 |
| Spending on phased clinical development of approved drugs by the US National Institutes of Health compared with industry EW Zhou, MJ Jackson, FD Ledley JAMA Health Forum 4 (7), e231921-e231921, 2023 | 5 | 2023 |
| Molecular Toxicology and Pathophysiology of Comorbid Alcohol Use Disorder and Post-Traumatic Stress Disorder Associated with Traumatic Brain Injury Z Wang, C Luo, EW Zhou, AF Sandhu, X Yuan, GE Williams, J Cheng, ... International journal of molecular sciences 24 (10), 8805, 2023 | 2 | 2023 |
| Melatonin and Other Neuroprotective Agents Target Molecular Mechanisms of Disease in Amyotrophic Lateral Sclerosis A Fotinos, Y Zhu, LLJ Mao, N Atassi, EW Zhou, S Ahmad, Y Guan, ... Melatonin, Neuroprotective Agents and Antidepressant Therapy, 869-903, 2016 | 1 | 2016 |
| Considering Returns on Federal Investment in the Negotiated “Maximum Fair Price” of Drugs Under the Inflation Reduction Act: an Analysis EW Zhou, PGC da Silva, D Quijada, FD Ledley | | 2024 |
| Comments Re: Draft Guidance Considering Exercise of March-In Rights-Docket No.: 230831-0207 FD Ledley, E Zhou | | 2024 |
| Tech Note 2023-1 NIH Contribution to Phased Clinical Development of Drugs Approved from 2010-2019 E Zhou, M Jackson, F Ledley | | 2023 |
